Modified Laparoscopic Anatomic Hepatectomy: Two-Surgeon Technique Combined with the Simple Extracorporeal Pringle Maneuver
June 16th, 2023
4.8K views
Here, we present a protocol to perform a modified laparoscopic anatomic hepatectomy using improved techniques and instruments.
Overview
This article presents a protocol for a modified laparoscopic anatomic hepatectomy, utilizing advanced techniques and instruments. The procedure is demonstrated in a video format, showcasing its application in a clinical setting.
Key Study Components
Area of Science
- Surgery
- Hepatology
- Oncology
Background
- The patient is a 54-year-old female with a liver mass.
- She has an elevated serum AFP level of 104 ng/mL.
- Imaging indicated a tumor in the liver segments S5 and S8.
- The diagnosis was primary hepatocellular carcinoma.
Purpose of Study
- To demonstrate a modified surgical technique for hepatectomy.
- To improve surgical outcomes using advanced instruments.
- To provide a comprehensive video protocol for educational purposes.
Methods Used
- Combination of CUSA and ultrasonic dissector.
- Two-surgeon technique for enhanced precision.
- Modified extracorporeal Pringle maneuver.
- Low central venous pressure technique to minimize blood loss.
Main Results
- The protocol was successfully implemented in the surgical procedure.
- Patient consent was obtained prior to surgery.
- The technique demonstrated effective tumor removal.
- Normal cardiopulmonary function was confirmed preoperatively.
Conclusions
- The modified laparoscopic technique is feasible and effective.
- Utilizing advanced instruments can enhance surgical precision.
- This protocol serves as a valuable resource for surgical education.
Frequently Asked Questions
What is the main focus of this article?
The article focuses on a modified laparoscopic anatomic hepatectomy protocol.
What techniques are highlighted in the procedure?
The procedure highlights the use of CUSA, ultrasonic dissector, and a two-surgeon technique.
What was the patient's diagnosis?
The patient was diagnosed with primary hepatocellular carcinoma.
How was patient consent handled?
Informed consent was obtained from the patient before the surgery.
What are the benefits of this surgical technique?
The technique aims to improve surgical outcomes and precision in tumor removal.
Is there a video demonstration available?
Yes, a video demonstration of the procedure is included in the article.
Executive Industry Relevance
Effective intraoperative hemostasis remains a critical challenge in surgical oncology and translational liver research, directly impacting procedural safety and downstream data integrity. The modified two-surgeon laparoscopic anatomic hepatectomy (LAH) protocol, integrating concurrent CUSA and ultrasonic dissector use with a simple extracorporeal Pringle maneuver, addresses bleeding control and workflow reproducibility. This approach enhances the reliability of surgical models for preclinical and translational studies requiring precise hepatic tissue manipulation.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Enables reproducible hepatic tissue resection for mechanistic studies and target validation in liver disease models.
- Reduces intraoperative bleeding, minimizing confounding variables in downstream biological analyses.
- Supports functional assessment of surgical interventions in disease-relevant systems.
Screening & Assay Development
- Provides standardized surgical conditions for generating consistent biological samples.
- Facilitates quantitative assessment of post-resection biomarkers and tissue responses.
- Improves assay reproducibility by controlling intraoperative variables such as blood loss and tissue trauma.
Translational & Preclinical Research
- Aligns with preclinical model requirements for evaluating surgical and interventional therapies in hepatology and oncology.
- Enables risk-adjusted advancement of surgical techniques into translational pipelines.
- Supports the development of predictive models for postoperative outcomes and biomarker discovery.
Pipeline & Workflow Integration
This protocol positions the modified LAH technique as a foundational step in the continuum from surgical model establishment to preclinical validation and translational research.
- Discovery Biology: Enhances hypothesis testing by enabling controlled hepatic resections and minimizing procedural variability.
- Screening: Standardizes sample preparation for downstream molecular and cellular assays.
- Analytics: Provides quantitative intraoperative and postoperative measurements, supporting comparative analyses across experimental arms.
- Translational Research: Bridges surgical innovation with preclinical model fidelity and biomarker alignment.
- Enterprise Reuse: Establishes a reproducible surgical workflow adaptable to diverse liver research applications.
Operational & Enterprise Impact
- Scientific Value: Increases predictive confidence in surgical and tissue-based studies by reducing intraoperative variability.
- Operational Value: Promotes standardization and reproducibility across research teams and experimental cohorts.
- Strategic Value: Enables more informed go/no-go decisions for advancing surgical techniques and related therapeutics.
- Portfolio Impact: Supports risk-adjusted prioritization of surgical and interventional research programs.
Implementation Considerations
- Requires expertise in advanced laparoscopic techniques and familiarity with CUSA and ultrasonic dissector instrumentation.
- Demands access to intraoperative imaging, hemostatic devices, and real-time monitoring infrastructure.
- Necessitates cross-team standardization of surgical protocols and perioperative management.
- May require adaptation for use in different preclinical or translational liver models.
- Practical limitations include patient selection criteria and exclusion of cases with advanced vascular invasion or severe portal hypertension.
Biopharma FAQs
Why does null hypothesis testing matter for intraoperative bleeding control?
Null hypothesis testing enables objective evaluation of whether the two-surgeon technique with Pringle maneuver significantly reduces intraoperative blood loss compared to standard approaches, supporting robust target validation in surgical research.
How does independent variable isolation fit the two-surgeon LAH workflow?
Isolating variables such as surgical technique, instrument use, and hemostatic strategy allows for clear attribution of outcomes like blood loss and operative field clarity, strengthening mechanistic de-risking in procedural optimization.
What do quantitative dependent variable measurements enable in this protocol?
Quantitative metrics such as estimated blood loss, operative time, and postoperative complication rates provide actionable data for comparing procedural efficacy and informing advancement decisions in translational research pipelines.
Why are replication requirements critical for cross-functional surgical teams?
Replication ensures that the modified LAH protocol yields consistent results across operators and settings, facilitating cross-team collaboration and standardization in multi-site preclinical or translational studies.
What statistical analysis capabilities are required before implementing this surgical protocol?
Robust statistical analysis is needed to compare intraoperative and postoperative outcomes, validate reproducibility, and support evidence-based adoption of the two-surgeon technique in research and development workflows.
